Trials 12 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04826224 | Dec 2021 → Aug 2025 | osteoarthritis | Shane A. Shapiro | Terminated | No outcome recorded |
| Phase 2/32 trials | ||||||
| Phase 2/3 | NCT03908827 | Dec 2019 → Dec 2022 | osteoarthritis, hip, osteoarthritis, knee | CAPRI Clinic | Withdrawn | No outcome recorded |
| Phase 2/3 | NCT01818310 | Sep 2012 → Sep 2018 | limb ischemia, type 2 diabetes mellitus | University Hospital Ostrava | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT04990128 | Jun 2026 → Jul 2027 expected | osteoarthritis, hip | The Cleveland Clinic | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07536399 | Apr 2026 → Dec 2027 expected | mouth disorder, temporomandibular joint disorder | Weill Medical College of Cornell University | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06003101 | Aug 2023 → Aug 2027 expected | — | Massachusetts General Hospital | Recruiting | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT06750757 | Feb 2025 → Feb 2027 expected | — | American Hip Institute | Not yet recruiting | No outcome recorded |
| Phase not applicable5 trials | ||||||
| — | NCT06040957 | Jan 2024 → Jan 2027 expected | osteoarthritis, knee | Rizzoli Orthopaedic Institute | Recruiting | No outcome recorded |
| — | NCT04475341 | Sep 2020 → Sep 2024 | osteochondritis dissecans | Academic Medical Center - University of Amsterdam | Unknown | No outcome recorded |
| — | NCT04716803 | Jul 2020 → Dec 2023 overdue | osteoarthritis, knee | University of California, San Diego | Recruiting | No outcome recorded |
| — | NCT02582489 | Dec 2017 → Nov 2026 expected | osteoarthritis, knee | Rush University Medical Center | Active not recruiting | No outcome recorded |
| — | NCT01285297 | Oct 2010 → Mar 2012 | Prinzmetal angina | Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc. | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bone Marrow Aspirate Concentrate | “This is a single site, randomized single blinded, two arm study researching the effects of bone marrow aspirate concentrate (BMAC) versus Triamcinolone in patients with hip...” NCT04990128 ↗11“A Pilot Study For The Use Of Human Autologous Bone Marrow Aspirate Concentrate (BMAC) Combined With Arthroscopic Surgery For Painful Shoulder Osteoarthritis” NCT04826224 ↗ “Autologous Bone Marrow Aspirate Concentrate (BMAC) for No-option_critical Limb Ischemia in Type-II Diabetes Mellitus Patients.” NCT01818310 ↗ “Bone Marrow Aspirate Concentrate (BMAC)” NCT03908827 ↗ |
| Known as | BMAC | “The primary objective of the study is to compare the safety and efficacy of a single intra-articular infiltration of Bone marrow aspirate concentrate (BMAC) with one of...” NCT06040957 ↗6“This is a single site, randomized single blinded, two arm study researching the effects of bone marrow aspirate concentrate (BMAC) versus Triamcinolone in patients with hip...” NCT04990128 ↗ “A Pilot Study For The Use Of Human Autologous Bone Marrow Aspirate Concentrate (BMAC) Combined With Arthroscopic Surgery For Painful Shoulder Osteoarthritis” NCT04826224 ↗ “Autologous Bone Marrow Aspirate Concentrate (BMAC) for No-option_critical Limb Ischemia in Type-II Diabetes Mellitus Patients.” NCT01818310 ↗ “one of them being bone marrow aspirate concentrate (BMAC) from the iliac crest.” NCT04475341 ↗ “Bone marrow aspirate concentrate (BMAC)” NCT06003101 ↗ “Injection of up to 18 mL BMAC” NCT01285297 ↗ |
| Modality | Cell therapy | “BMAC consists of mesenchymal stem cells, hematopoietic stem cells and growth factors” NCT04475341 ↗ |
| Route | Other | “Injection of bone marrow aspirate concentrate into reversibly ischemic myocardium” NCT01285297 ↗ |